Speaking to Outsourcing-Pharma Michael Rosenberg, CEO of Health Decisions, explained that adopting adaptive methods, in both design and operations, can help improve the efficiency of trials for personalised medicines.
For instance, use of adaptive operations can help speed patient recruitment, a particular problem when conducting trials on small, specific populations, by identifying which methods are proving effective and adjusting accordingly.
Furthermore, use of adaptive design can give information on outcomes and modifiers during the course of a trial, giving companies the ability to change practices part way through the study.
